 |
Previous Article | Next Article 
The Journal of Neuroscience, May 1, 2002, 22(9):3326-3331
MINI REVIEW
Cannabinoid Addiction: Behavioral Models and Neural
Correlates
Rafael
Maldonado1 and
Fernando
Rodríguez de
Fonseca2
1 Laboratori de Neurofarmacologia, Facultat de
Cienciés de la Salut i de la Vida, Universitat Pompeu Fabra,
08003 Barcelona, Spain, and 2 Fundación Hospital
Carlos Haya, Unidad de Investigación, 29010 Málaga, Spain
The use of cannabis sativa preparations as
recreational drugs can be traced back to the earliest civilizations.
However, animal models of cannabinoid addiction allowing the
exploration of neural correlates of cannabinoid abuse have been
developed only recently. We review these models and the role of the
CB1 cannabinoid receptor, the main target of natural
cannabinoids, and its interaction with opioid and dopamine transmission
in reward circuits. Extensive reviews on the molecular basis of
cannabinoid action are available elsewhere (Piomelli et al., 2000;
Schlicker and Kathmann, 2001).
Copyright © 2002 Society for Neuroscience 0270-6474/02/2293326-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
N. Dobrosi, B. I. Toth, G. Nagy, A. Dozsa, T. Geczy, L. Nagy, C. C. Zouboulis, R. Paus, L. Kovacs, and T. Biro
Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling
FASEB J,
October 1, 2008;
22(10):
3685 - 3695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tonini, S. Ciardo, M. Cerovic, T. Rubino, D. Parolaro, M. Mazzanti, and R. Zippel
ERK-Dependent Modulation of Cerebellar Synaptic Plasticity after Chronic {Delta}9-Tetrahydrocannabinol Exposure
J. Neurosci.,
May 24, 2006;
26(21):
5810 - 5818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yao, K. McFarland, P. Fan, Z. Jiang, T. Ueda, and I. Diamond
Adenosine A2a blockade prevents synergy between {micro}-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats
PNAS,
May 16, 2006;
103(20):
7877 - 7882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Justinova, M. Solinas, G. Tanda, G. H. Redhi, and S. R. Goldberg
The Endogenous Cannabinoid Anandamide and Its Synthetic Analog R(+)-Methanandamide Are Intravenously Self-Administered by Squirrel Monkeys
J. Neurosci.,
June 8, 2005;
25(23):
5645 - 5650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Le Foll and S. R. Goldberg
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
J. Pharmacol. Exp. Ther.,
March 1, 2005;
312(3):
875 - 883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. RODRIGUEZ de FONSECA, I. DEL ARCO, F. J. BERMUDEZ-SILVA, A. BILBAO, A. CIPPITELLI, and M. NAVARRO
THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY
Alcohol Alcohol.,
January 1, 2005;
40(1):
2 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Dietrich and W F McDaniel
Endocannabinoids and exercise
Br. J. Sports Med.,
October 1, 2004;
38(5):
536 - 541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yao, P. Fan, Z. Jiang, W. S. Mailliard, A. S. Gordon, and I. Diamond
Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-{beta}{gamma} dimers
PNAS,
November 25, 2003;
100(24):
14379 - 14384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cami and M. Farre
Drug Addiction
N. Engl. J. Med.,
September 4, 2003;
349(10):
975 - 986.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. FREUND, I. KATONA, and D. PIOMELLI
Role of Endogenous Cannabinoids in Synaptic Signaling
Physiol Rev,
July 1, 2003;
83(3):
1017 - 1066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. White
A Behavioral/Systems Approach to the Neuroscience of Drug Addiction
J. Neurosci.,
May 1, 2002;
22(9):
3303 - 3305.
[Full Text]
[PDF]
|
 |
|
|